RENAL CARCINOMA (CLEAR AND NON-CLEAR CELL)

Clinical trials for RENAL CARCINOMA (CLEAR AND NON-CLEAR CELL) explained in plain language.

Never miss a new study

Get alerted when new RENAL CARCINOMA (CLEAR AND NON-CLEAR CELL) trials appear

Sign up with your email to follow new studies for RENAL CARCINOMA (CLEAR AND NON-CLEAR CELL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug EXS74539 enters first human tests for tough cancers

Disease control Recruiting now

This early-stage study tests a new drug called EXS74539 in about 40 adults with certain solid tumors, including lung, prostate, ovarian, and breast cancers. The main goal is to find a safe dose and check for side effects. Researchers will also watch for any signs that the drug sh…

Matched conditions: RENAL CARCINOMA (CLEAR AND NON-CLEAR CELL)

Phase: PHASE1 • Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 29, 2026 15:05 UTC

RENAL CARCINOMA (CLEAR AND NON-CLEAR CELL)

Get alerted when new RENAL CARCINOMA (CLEAR AND NON-CLEAR CELL) trials appear

New drug EXS74539 enters first human tests for tough cancers